Obesity is considered to promote PI3K/Akt signaling through mechanisms involving increased levels of insulin and leptin, and possible relationships between obesity, IGFBP7 expression, and ganitumab sensitivity deserve further study31,32. This evidence concerns the gene IGFBP7 and obesity due to melanocortin 4 receptor deficiency.